vs

Side-by-side financial comparison of ITRON, INC. (ITRI) and STEPAN CO (SCL). Click either name above to swap in a different company.

STEPAN CO is the larger business by last-quarter revenue ($604.5M vs $587.0M, roughly 1.0× ITRON, INC.). ITRON, INC. runs the higher net margin — 9.1% vs 3.3%, a 5.9% gap on every dollar of revenue. On growth, STEPAN CO posted the faster year-over-year revenue change (1.9% vs -3.3%). Over the past eight quarters, STEPAN CO's revenue compounded faster (4.2% CAGR vs -1.8%).

Itron, Inc. is an American technology company that offers products and services for energy and water resource management. It is headquartered in Liberty Lake, Washington, United States. The company's products measure and analyze electricity, gas and water consumption. Its products include electricity, gas, water and thermal energy measurement devices and control technology, communications systems, software, as well as managed and consulting services.

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

ITRI vs SCL — Head-to-Head

Bigger by revenue
SCL
SCL
1.0× larger
SCL
$604.5M
$587.0M
ITRI
Growing faster (revenue YoY)
SCL
SCL
+5.2% gap
SCL
1.9%
-3.3%
ITRI
Higher net margin
ITRI
ITRI
5.9% more per $
ITRI
9.1%
3.3%
SCL
Faster 2-yr revenue CAGR
SCL
SCL
Annualised
SCL
4.2%
-1.8%
ITRI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ITRI
ITRI
SCL
SCL
Revenue
$587.0M
$604.5M
Net Profit
$53.6M
$19.7M
Gross Margin
40.3%
10.7%
Operating Margin
11.5%
4.7%
Net Margin
9.1%
3.3%
Revenue YoY
-3.3%
1.9%
Net Profit YoY
-18.0%
EPS (diluted)
$1.18
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ITRI
ITRI
SCL
SCL
Q1 26
$587.0M
$604.5M
Q4 25
$571.7M
$553.9M
Q3 25
$581.6M
$590.3M
Q2 25
$606.8M
$594.7M
Q1 25
$607.2M
$593.3M
Q4 24
$612.9M
$525.6M
Q3 24
$615.5M
$546.8M
Q2 24
$609.1M
$556.4M
Net Profit
ITRI
ITRI
SCL
SCL
Q1 26
$53.6M
$19.7M
Q4 25
$101.6M
$5.0M
Q3 25
$65.6M
$10.8M
Q2 25
$68.3M
$11.3M
Q1 25
$65.5M
$19.7M
Q4 24
$58.1M
$3.4M
Q3 24
$78.0M
$23.6M
Q2 24
$51.3M
$9.5M
Gross Margin
ITRI
ITRI
SCL
SCL
Q1 26
40.3%
10.7%
Q4 25
40.5%
9.3%
Q3 25
37.7%
12.0%
Q2 25
36.9%
12.1%
Q1 25
35.8%
12.7%
Q4 24
34.9%
10.8%
Q3 24
34.1%
13.8%
Q2 24
34.6%
12.5%
Operating Margin
ITRI
ITRI
SCL
SCL
Q1 26
11.5%
4.7%
Q4 25
13.8%
1.9%
Q3 25
14.1%
3.7%
Q2 25
12.6%
3.0%
Q1 25
12.6%
4.8%
Q4 24
10.2%
1.5%
Q3 24
12.0%
4.4%
Q2 24
10.6%
3.4%
Net Margin
ITRI
ITRI
SCL
SCL
Q1 26
9.1%
3.3%
Q4 25
17.8%
0.9%
Q3 25
11.3%
1.8%
Q2 25
11.3%
1.9%
Q1 25
10.8%
3.3%
Q4 24
9.5%
0.6%
Q3 24
12.7%
4.3%
Q2 24
8.4%
1.7%
EPS (diluted)
ITRI
ITRI
SCL
SCL
Q1 26
$1.18
$0.86
Q4 25
$2.20
$0.22
Q3 25
$1.41
$0.47
Q2 25
$1.47
$0.50
Q1 25
$1.42
$0.86
Q4 24
$1.26
$0.14
Q3 24
$1.70
$1.03
Q2 24
$1.10
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ITRI
ITRI
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$712.9M
Total DebtLower is stronger
$328.4M
Stockholders' EquityBook value
$1.6B
$1.2B
Total Assets
$4.0B
$2.3B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ITRI
ITRI
SCL
SCL
Q1 26
$712.9M
Q4 25
$1.0B
$132.7M
Q3 25
$1.3B
$118.5M
Q2 25
$1.2B
$88.9M
Q1 25
$1.1B
$107.5M
Q4 24
$1.1B
$99.7M
Q3 24
$982.5M
$147.3M
Q2 24
$920.6M
$124.7M
Total Debt
ITRI
ITRI
SCL
SCL
Q1 26
$328.4M
Q4 25
$1.3B
$626.7M
Q3 25
$655.5M
Q2 25
$658.0M
Q1 25
$659.3M
Q4 24
$1.3B
$625.4M
Q3 24
$1.3B
$688.5M
Q2 24
$1.3B
$657.1M
Stockholders' Equity
ITRI
ITRI
SCL
SCL
Q1 26
$1.6B
$1.2B
Q4 25
$1.7B
$1.2B
Q3 25
$1.7B
$1.2B
Q2 25
$1.6B
$1.2B
Q1 25
$1.5B
$1.2B
Q4 24
$1.4B
$1.2B
Q3 24
$1.3B
$1.2B
Q2 24
$1.2B
$1.2B
Total Assets
ITRI
ITRI
SCL
SCL
Q1 26
$4.0B
$2.3B
Q4 25
$3.7B
$2.4B
Q3 25
$3.7B
$2.4B
Q2 25
$3.6B
$2.4B
Q1 25
$3.5B
$2.4B
Q4 24
$3.4B
$2.3B
Q3 24
$3.4B
$2.4B
Q2 24
$3.3B
$2.3B
Debt / Equity
ITRI
ITRI
SCL
SCL
Q1 26
0.28×
Q4 25
0.74×
0.50×
Q3 25
0.53×
Q2 25
0.53×
Q1 25
0.55×
Q4 24
0.91×
0.53×
Q3 24
0.94×
0.56×
Q2 24
1.02×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ITRI
ITRI
SCL
SCL
Operating Cash FlowLast quarter
$85.5M
Free Cash FlowOCF − Capex
$79.0M
FCF MarginFCF / Revenue
13.5%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.60×
TTM Free Cash FlowTrailing 4 quarters
$394.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ITRI
ITRI
SCL
SCL
Q1 26
$85.5M
Q4 25
$119.3M
$60.0M
Q3 25
$117.8M
$69.8M
Q2 25
$96.7M
$11.2M
Q1 25
$72.1M
$6.9M
Q4 24
$79.8M
$68.3M
Q3 24
$65.3M
$22.7M
Q2 24
$51.7M
$29.5M
Free Cash Flow
ITRI
ITRI
SCL
SCL
Q1 26
$79.0M
Q4 25
$111.5M
$25.4M
Q3 25
$113.4M
$40.2M
Q2 25
$90.7M
$-14.4M
Q1 25
$67.5M
$-25.8M
Q4 24
$70.2M
$32.1M
Q3 24
$58.7M
$-4.0M
Q2 24
$44.6M
$-208.0K
FCF Margin
ITRI
ITRI
SCL
SCL
Q1 26
13.5%
Q4 25
19.5%
4.6%
Q3 25
19.5%
6.8%
Q2 25
14.9%
-2.4%
Q1 25
11.1%
-4.3%
Q4 24
11.4%
6.1%
Q3 24
9.5%
-0.7%
Q2 24
7.3%
-0.0%
Capex Intensity
ITRI
ITRI
SCL
SCL
Q1 26
Q4 25
1.4%
6.3%
Q3 25
0.8%
5.0%
Q2 25
1.0%
4.3%
Q1 25
0.8%
5.5%
Q4 24
1.6%
6.9%
Q3 24
1.1%
4.9%
Q2 24
1.2%
5.3%
Cash Conversion
ITRI
ITRI
SCL
SCL
Q1 26
1.60×
Q4 25
1.17×
11.99×
Q3 25
1.80×
6.44×
Q2 25
1.41×
0.99×
Q1 25
1.10×
0.35×
Q4 24
1.37×
20.38×
Q3 24
0.84×
0.96×
Q2 24
1.01×
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ITRI
ITRI

Product revenues$477.8M81%
Service revenues$109.2M19%

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

Related Comparisons